Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Heterologous prime/boost immunizations of rhesus monkeys using chimpanzee adenovirus vectors.

Santra S, Sun Y, Korioth-Schmitz B, Fitzgerald J, Charbonneau C, Santos G, Seaman MS, Ratcliffe SJ, Montefiori DC, Nabel GJ, Ertl HC, Letvin NL.

Vaccine. 2009 Sep 25;27(42):5837-45. doi: 10.1016/j.vaccine.2009.07.050. Epub 2009 Aug 4.

2.

Human immunodeficiency virus vaccine trials.

O'Connell RJ, Kim JH, Corey L, Michael NL.

Cold Spring Harb Perspect Med. 2012 Dec 1;2(12):a007351. doi: 10.1101/cshperspect.a007351. Review.

3.

Pre-existing immunity against Ad vectors: humoral, cellular, and innate response, what's important?.

Fausther-Bovendo H, Kobinger GP.

Hum Vaccin Immunother. 2014;10(10):2875-84. doi: 10.4161/hv.29594. Review.

PMID:
25483662
4.

The "STEP-wise" future of adenovirus-based HIV vaccines.

Patterson LJ.

Curr Med Chem. 2011;18(26):3981-6. Review.

PMID:
21824093
5.

Adenovirus vector-based vaccines for human immunodeficiency virus type 1.

Barouch DH, Nabel GJ.

Hum Gene Ther. 2005 Feb;16(2):149-56. Review.

PMID:
15761255
6.

Viral vectors as vaccine platforms: from immunogenicity to impact.

Ewer KJ, Lambe T, Rollier CS, Spencer AJ, Hill AV, Dorrell L.

Curr Opin Immunol. 2016 Aug;41:47-54. doi: 10.1016/j.coi.2016.05.014. Epub 2016 Jun 7. Review.

PMID:
27286566
Items per page

Supplemental Content

Write to the Help Desk